Therapeutic effects of nanosilibinin in valproic acid-zebrafish model of autism spectrum disorder: Focusing on Wnt signaling pathway and autism spectrum disorder-related cytokines

被引:0
作者
Karimi, Zahra [1 ]
Zarifkar, Asadollah [2 ]
Mirzaei, Esmaeil [3 ]
Dianatpour, Mehdi [4 ,5 ]
Dara, Mahintaj [4 ]
Aligholi, Hadi [1 ]
机构
[1] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Shiraz, Iran
[2] Shiraz Univ Med Sci, Sch Med, Dept Physiol, Shiraz, Iran
[3] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Med Nanotechnol, Shiraz, Iran
[4] Shiraz Univ Med Sci, Stem Cell Technol Res Ctr, Shiraz, Iran
[5] Shiraz Univ Med Sci, Sch Med, Dept Med Genet, Shiraz, Iran
关键词
autism spectrum disorder; cytokine; silibinin; valproic acid; Wnt signaling pathway; zebrafish; RAT MODEL; SILIBININ; CHILDREN; EXPOSURE; BEHAVIOR; BRAIN; EXPRESSION; ANTICONVULSANT; ASSOCIATION; PREVALENCE;
D O I
10.1002/jdn.10348
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this study, we delved into the intricate world of autism spectrum disorder (ASD) and its connection to the disturbance in the Wnt signaling pathway and immunological abnormalities. Our aim was to evaluate the impact of silibinin, a remarkable modulator of both the Wnt signaling pathway and the immune system, on the neurobehavioral and molecular patterns observed in a zebrafish model of ASD induced by valproic acid (VPA). Because silibinin is a hydrophobic molecule and highly insoluble in water, it was used in the form of silibinin nanoparticles (nanosilibinin, NS). After assessing survival, hatching rate, and morphology of zebrafish larvae exposed to different concentrations of NS, the appropriate concentrations were chosen. Then, zebrafish embryos were exposed to VPA (1 mu M) and NS (100 and 200 mu M) at the same time for 120 h. Next, anxiety and inattentive behaviors and the expression of CHD8, CTNNB, GSK3beta, LRP6, TNFalpha, IL1beta, and BDNF genes were assessed 7 days post fertilization. The results indicated that higher concentrations of NS had adverse effects on survival, hatching, and morphological development. The concentrations of 100 and 200 mu M of NS could ameliorate the anxiety-like behavior and learning deficit and decrease ASD-related cytokines (IL1beta and TNFalpha) in VPA-treated larvae. In addition, only 100 mu M of NS prevented raising the gene expression of Wnt signaling-related factors (CHD8, CTNNB, GSK3beta, and LRP6). In conclusion, NS treatment for the first 120 h showed therapeutic effect on an autism-like phenotype probably via reducing the expression of pro-inflammatory cytokines genes and changing the expression of Wnt signaling components genes. Zebrafish eggs were exposed to valproic acid and valproic acid + nanosilibinin for 120 h post fertilization. Behavioral and molecular test were assessed in 7 days post fertilization. Nanosilibinin decreased anxiety-like behavior, learning impairment and the expression of autism related genes in valproic treated zebrafish. image
引用
收藏
页码:454 / 468
页数:15
相关论文
共 50 条
  • [21] Timing and Intertemporal Choice Behavior in the Valproic Acid Rat Model of Autism Spectrum Disorder
    William E. DeCoteau
    Adam E. Fox
    Journal of Autism and Developmental Disorders, 2022, 52 : 2414 - 2429
  • [22] Timing and Intertemporal Choice Behavior in the Valproic Acid Rat Model of Autism Spectrum Disorder
    DeCoteau, William E.
    Fox, Adam E.
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2022, 52 (06) : 2414 - 2429
  • [23] Oral Supplementation with Maca Improves Social Recognition Deficits in the Valproic Acid Animal Model of Autism Spectrum Disorder
    Fu, Pinyue
    Luo, Shuxin
    Liu, Zhongyu
    Furuhara, Kazumi
    Tsuji, Takahiro
    Higashida, Haruhiro
    Yokoyama, Shigeru
    Zhong, Jing
    Tsuji, Chiharu
    BRAIN SCIENCES, 2023, 13 (02)
  • [24] Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats
    Abhishek, Mishra
    Rubal, Singla
    Rohit, Kumar
    Rupa, Joshi
    Phulen, Sarma
    Gurjeet, Kaur
    Raj, Sharma Amit
    Manisha, Prajapat
    Alka, Bhatia
    Ramprasad, Pallola
    Bikash, Medhi
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 293
  • [25] Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats
    Mirza, Roohi
    Sharma, Bhupesh
    BRAIN RESEARCH BULLETIN, 2019, 147 : 36 - 46
  • [26] Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder
    Sandhu, Arushi
    Rawat, Kajal
    Gautam, Vipasha
    Sharma, Antika
    Kumar, Anil
    Saha, Lekha
    BRAIN RESEARCH, 2023, 1815
  • [27] Oxytocin protective effects on zebrafish larvae models of autism-like spectrum disorder
    Rahmati-Holasoo, Hooman
    Maghsoudi, Armin Salek
    Akbarzade, Milad
    Gholami, Mahdi
    Shadboorestan, Amir
    Vakhshiteh, Faezeh
    Armandeh, Maryam
    Hassani, Shokoufeh
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2023, 26 (03) : 316 - 325
  • [28] Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder
    Kuo, Hsiao-Ying
    Liu, Fu-Chin
    BIOMEDICINES, 2022, 10 (03)
  • [29] Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder
    Lu, Xiao-Yu
    Li, Meng-Qing
    Li, Yong-Tao
    Yao, Jia-Yu
    Zhang, Lin-Xuan
    Zeng, Ze-Hao
    Chen, Zhao-Rong
    Li, Chang-Qi
    Zhou, Xin-Fu
    Li, Fang
    NEUROPHARMACOLOGY, 2024, 258
  • [30] Association of the retinol to all-trans retinoic acid pathway with autism spectrum disorder
    Feng, Yu-Ru
    Zhang, Qian
    Miao, Jing-Kun
    Yang, Ting
    Chen, Jie
    Chen, Hong-Yu
    Mou, Qiu-Hong
    Xiang, Xue-Li
    Long, Dan
    Wei, Qiu-Hong
    Wu, Yuan
    Li, Ting-Yu
    WORLD JOURNAL OF PEDIATRICS, 2024, 20 (10) : 1043 - 1058